Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Supriya Lifescience expands solar power capacity with 5 MWp facility in Maharashtra
Company strengthens renewable energy commitment with latest solar project
USV launches Xenia: Empagliflozin and its combinations for diabetes care in India
With the loss of exclusivity, Empagliflozin and its combinations are now available at one-fifth the cost, enhancing affordability
Cipla, Formosa sign multi-regional licensing deal for Clobetasol Suspension
This partnership aims to enhance ophthalmic care by providing treatment for post- operative inflammation and pain in patients…
Shilpa Biologicals partners with mAbTree Biologics for novel immuno-oncology asset
Shilpa to undertake both development and commercial supply for mAbTree’s novel checkpoint inhibitor
Lupin gains tentative USFDA approval for Amifampridine Tablets
Amifampridine Tablets, 10 mg, are bioequivalent to Firdapse Tablets, 10 mg of Catalyst Pharmaceuticals
Peptris Technologies out-licenses AI-discovered drug candidate to Revio Therapeutics
Under the agreement, Revio Therapeutics will hold commercialisation rights to PEPR124 (RT001) in all markets except in BRICS…
AstraZeneca to acquire EsoBiotec to advance cell therapy ambition
EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium
Zydus receives final USFDA approval for Eluxadoline Tablets, 75 mg and 100 mg
Eluxadoline is a mu-opioid receptor agonist, indicated in adults for the treatment of irritable bowel syndrome with diarrhoea…
AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma…
Ramandeep Singh, Vice President, Life Sciences and Healthcare, India, Clarivate, discusses the latest innovative R&D,…